SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-023177
Filing Date
2024-02-29
Accepted
2024-02-29 16:36:01
Documents
80
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K xene-20231231.htm   iXBRL 10-K 3056723
2 EX-4.3 xene-ex4_3.htm EX-4.3 45793
3 EX-10.27 xene-ex10_27.htm EX-10.27 48952
4 EX-10.28 xene-ex10_28.htm EX-10.28 157687
5 EX-23.1 xene-ex23_1.htm EX-23.1 5971
6 EX-31.1 xene-ex31_1.htm EX-31.1 13276
7 EX-31.2 xene-ex31_2.htm EX-31.2 12966
8 EX-32.1 xene-ex32_1.htm EX-32.1 10286
9 EX-32.2 xene-ex32_2.htm EX-32.2 9999
10 EX-97 xene-ex97.htm EX-97 46507
11 GRAPHIC img118510877_0.jpg GRAPHIC 70455
12 GRAPHIC img254092295_0.jpg GRAPHIC 97163
13 GRAPHIC img254092295_1.jpg GRAPHIC 138204
  Complete submission text file 0000950170-24-023177.txt   11140458

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT xene-20231231.xsd EX-101.SCH 1242035
82 EXTRACTED XBRL INSTANCE DOCUMENT xene-20231231_htm.xml XML 1703256
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36687 | Film No.: 24704412
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)